What is the new depression medication for 2025? Recent advancements in pharmacological treatments
•
3 min read
Depression affects millions globally, with approximately one-third of individuals not finding relief with existing medications. Advances in pharmacology and psychiatric care have introduced significant new options. The FDA expanded the use of Spravato (esketamine) in January 2025, marking a key development for those struggling with treatment-resistant depression.
